A NEW DRUG TO TREAT
INCURABLE HIGH CHOLESTEROL
Australia: A
new drug developed for patients with hereditary high cholesterol has shown
remarkable results in early trials, reducing rates by up to 65%.
This medicine is
taken orally which can prove to be a cure for previously incurable
conditions. Genetically increased cholesterol cannot be normalized by
diet, medication, exercise or other measures. It is lipoprotein A
cholesterol that increases the risk of high blood pressure, heart disease and
stroke. Experts call it a subtype of LDL cholesterol. which thickens
the blood and narrows the blood vessels.
Professor Stephen
Nicholls of Monash University and other scientists have named the drug
'myovaliplin', which is taken in pill form and prevents the body from making
lipoprotein A. It achieves its goal by breaking down genetic barriers.
In this regard,
experts included 114 people in the clinical trial. Of these, 89 patients
were given the new drug and the remaining 25 were given a dummy drug
(placebo). The average age of the people in the survey was 32
years. Cholesterol levels were measured by taking blood samples from all
participants before and after the trial. In some patients, the amount of
lipoprotein A started to decrease on the second day, and at 14 days its amount
was reduced by 64%, which is a significant improvement.
However, before the official
sale of 'Muvaliplin', it will be tested on a large number of patients and any
adverse side effects after the treatment will also be tested. It is
expected that the drug will be widely available in the next few years.
